We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $9.86M
1-Year Est. Return 9.93%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
Cap. Flow
+$23.3M
Cap. Flow %
11.78%
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396

Top Buys

Rank Stock Value
1
DK icon
Delek US
DK
+$871K
2
AVGO icon
Broadcom
AVGO
+$691K
3
A icon
Agilent Technologies
A
+$650K
4
TLS icon
Telos
TLS
+$640K
5
PGY icon
Pagaya Technologies
PGY
+$627K

Top Sells

Rank Stock Value
1
ARRY icon
Array Technologies
ARRY
+$730K
2
VRT icon
Vertiv
VRT
+$639K
3
ZVRA icon
Zevra Therapeutics
ZVRA
+$635K
4
BOW
Bowhead Specialty Holdings
BOW
+$608K
5
RIGL icon
Rigel Pharmaceuticals
RIGL
+$581K

Sector Composition

Rank Sector Weight
1 Technology 18.19%
2 Industrials 15.13%
3 Financials 12.4%
4 Consumer Discretionary 11.79%
5 Healthcare 11.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RC
951
Ready Capital
RC
$267M
– –
-49,449
Closed -$191K
RELY icon
952
Remitly
RELY
$4.79B
– –
-15,870
Closed -$259K
REPX icon
953
Riley Exploration Permian
REPX
$744M
– –
-10,522
Closed -$285K
REVG
954
DELISTED
REV Group
REVG
– –
-6,437
Closed -$365K
RF icon
955
Regions Financial
RF
$26.4B
– –
-9,649
Closed -$254K
RGP icon
956
Resources Connection
RGP
$131M
– –
-53,142
Closed -$268K
RIGL icon
957
Rigel Pharmaceuticals
RIGL
$693M
– –
-20,522
Closed -$581K
RMNI icon
958
Rimini Street
RMNI
$439M
– –
-48,205
Closed -$226K
RMR icon
959
The RMR Group
RMR
$350M
– –
-13,047
Closed -$205K
RNG icon
960
RingCentral
RNG
$4.64B
– –
-13,738
Closed -$389K
ROAD icon
961
Construction Partners
ROAD
$5.94B
– –
-1,991
Closed -$253K
ROK icon
962
Rockwell Automation
ROK
$51.1B
– –
-647
Closed -$226K
RPAY icon
963
Repay Holdings
RPAY
$339M
– –
-27,759
Closed -$145K
RSKD icon
964
Riskified
RSKD
$709M
– –
-14,863
Closed -$69.6K
RWAY icon
965
Runway Growth Finance
RWAY
$233M
– –
-22,929
Closed -$233K
RXO icon
966
RXO
RXO
$3.78B
– –
-13,201
Closed -$203K
RYAAY icon
967
Ryanair
RYAAY
$30.2B
– –
-5,976
Closed -$360K
RYN icon
968
Rayonier
RYN
$6.61B
– –
-13,116
Closed -$332K
SBRA icon
969
Sabra Healthcare REIT
SBRA
$5.65B
– –
-15,025
Closed -$280K
SDGR icon
970
Schrodinger
SDGR
$1.14B
– –
-14,254
Closed -$286K
SEDG icon
971
SolarEdge
SEDG
$2.5B
– –
-13,055
Closed -$483K
SHCO
972
DELISTED
Soho House & Co
SHCO
– –
-18,103
Closed -$160K
SIGA icon
973
SIGA Technologies
SIGA
$223M
– –
-15,061
Closed -$138K
SKT icon
974
Tanger
SKT
$4.85B
– –
-9,078
Closed -$307K
SKWD icon
975
Skyward Specialty Insurance
SKWD
$2.51B
– –
-5,980
Closed -$284K
37 38
39
40 41

Similar funds

BS
BCI Securities Miami, Florida $10.1M AUM
RG
Raine Group New York $10.5M AUM 23.14% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
DFA
Davies Financial Advisors Murrieta, California $10.9M AUM 21.57% 1-Year Est. Return
CCP
Caden Capital Partners Santa Monica, California $8.12M AUM 16.97% 1-Year Est. Return
FRT
FTX Recovery Trust League City, Texas $11.8M AUM
VH
Vitol Holding Rotterdam, Netherlands $11.9M AUM 27.28% 1-Year Est. Return

PharVision Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.

  • PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
  • PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
  • PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
  • PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
  • PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
  • PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
  • PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.